Home > Insider Trading > Filing (0001628280-21-001395)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
727207	Accelerate Diagnostics Inc	AXDX	Laboratory Analytical Instruments (3826)	841072256

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1556290	Steven Reichling	C/O Accelerate Diagnostics, Inc. 3950 S. Country Club Road, Suite 470 Tucson AZ 85714	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-12-16	3,142	$0.00	16,442	No	4	M	Direct
Common Stock	Disposition	2020-12-17	859	$7.37	15,583	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Restricted Stock Units	Disposition	2020-12-16	3,142	$0.00	3,142	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of common stock of Accelerate Diagnostics, Inc. (the "Issuer").
The number of shares reported in Column 5 represents the number of shares of the Issuer's common stock beneficially owned by the reporting person as of the date of this Form 4 filing and reflects the transactions reported in the Form 4 filed on January 27, 2021 by the reporting person.
Shares sold solely to pay taxes due upon the vesting of restricted stock units.
On June 29, 2020, the reporting person was granted restricted stock units, which vested on December 16, 2020. Upon vesting, the reporting person received such number of shares of the Issuer's common stock equal to the number of restricted stock units that vested.
Not applicable.